Quiz 3: Lipids Disorders/Diseases Flashcards
Type I hyperlipoproteinemia: elevated chylomicrons
Serum appearance: Creamy layer of chylomicrons over clear serum
Total cholesterol: normal - moderately elevated
Triglyceride: Extremely elevated
Type IIa hyperlipoproteinemia: Increased LDL
Serum appearance: Clear
Total cholesterol: Generally elevated
Triglyceride: Normal
Type IIb hyperlipoproteinemia: Increased LDL and VLDL
Serum appearance: Clear or slightly turbid
Total cholesterol: Elevated
Triglyceride: Elevated
Type III hyperlipoproteinemia: Increased IDL
Serum appearance: Creamy layer sometimes over a turbid layer
Total cholesterol: Elevated
Triglyceride: Elevated
Type IV hyperlipoproteinemia: Increased VLDL
Serum appearance: Turbid
Total cholesterol: Normal - slightly elevated
Triglyceride: Moderately - severely elevated
Type V hyperlipoproteinemia: Increased VLDL and chylomicrons
Characterized by increased VLDL and chylomicrons
Serum appearance: Turbid with creamy layer
Total cholesterol: Slightly - moderately elevated
Triglyceride: Severely elevated
Familial Combined Hyperlipidemia (FCHL)
Most common familial form, increased plasma levels of total cholesterol and LDL, or triglycerides, HDL may be decreased
Hyperapobetalipoproteinemia
VLDL and B-100 overproduction in Liver
LDL: normal - moderate elevation
Total cholesterol/triglyceride: normal - elevated
HDL: decreased
Familial hypertriglyceridemia
Characterized by moderate elevation of triglycerides and excessive VLDL production, cholesterol is also increased
HDL is decreased
Secondary Causes: Hormonal imbalance, Diabetes mellitus (increased fatty acid synthesis), Nephrosis
+ Can cause pancreatitis
Treatment- diet, drugs if needed
Familial Hypercholesterolemia
Characterized by increased LDL cholesterol due to deficient LDL receptor
Plasma triglyceride: normal - slightly increased
Plasma HDL cholesterol: slightly decreased
Treatment: Low fat low cholesterol diet, Physical activity, Statins or drugs if needed
Secondary lipoproteinemia
Conditions that cause abnormal metabolization of lipoproteins: diabetes mellitus hypothyroidism obesity pregnancy nephrotic syndrome pancreatitis alcoholism myxedema
Abetalipoproteinemia (hypolipoproteinemia)
Total cholesterol very low, triglycerides extremely low, no LDL
Hypobetalipoproteinemia (hypolipoproteinemia)
Low total cholesterol, normal - low triglyceride level
No increased risk of coronary heart disease
Hypoalphalipoproteinemia (hypolipoproteinemia)
Severely elevated triglyceride level, low HDL
Increased risk of coronary heart disease
Tangier Disease
No HDL, LDL low, total cholesterol low, triglyceride level low to slightly increased
Increased risk of coronary heart disease
Genetic deficiency of transporter protein (Cannot get cholesterol out of cells)
Arteriosclerosis
Disease of the arteries, thickening, hardening, loss of elasticity in artery walls
Atherosclerosis
Gr. sklerosis, hardness, indicates cholesterol-lipid-calcium deposits in artery walls.
Potential consequences of hyperlipidemias
Coronary artery disease (CAD): Angina, Myocardial Infarcts
Peripheral vascular disease (PVD): plaque in arteries in arms and legs
Coronary vascular disease (CVD): vessels in brain
Treatment options to lower the risk of coronary heart disease
Reduce hepatic cholesterol synthesis: statins (Reduces LDL)
Reduce cholesterol absorption from GI: ezetimibe
Reduce bile acid absorption from GI: resins
Decrease secretion of lipoproteins: niacin (Reduces LDL and increases HDL)
Increase peripheral clearance of lipoproteins: fibrates (Reduces Trig and VLDL and increases HDL)
Gaucher disease
Most common lipid storage disorder
Enzyme deficiency: glucocerebrosidase
Fatty material collects in spleen, liver, kidneys, lung, brain, and bone marrow
Treated with enzyme replacement therapy
Niemann-Pick disease
Fat and cholesterol in cells of liver, spleen, bone marrow, lungs and brain – no cure
Fabry disease - x-linked disease
Enzyme deficiency: alpha-galactosidase-A
Fatty build up in nervous system, eyes, kidneys, CVS
Treated with enzyme replacement therapy
Farber’s disease
Enzyme deficiency: ceramidase
Fatty build up in joints, tissues, and central nervous system. Corticosteroids to relieve pain.
Gangliosidoses
Abnormal storage of lipid in nerve cells
GM1. Enzyme deficiency- beta-galactosidase
GM2. Enzyme deficiency beta-hexosaminidase
Tay-Sachs disease- no treatment, Anticonvulsant therapy
Sandhoff disease